newsfilter
← Latest News
Business Wire·

Alpine Immune Sciences Reports First Quarter 2023 Financial Results

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results for the